Follow us on:
Breaking News
August 7, 2026
CP Direct: Friday Edition
Breaking News
Featured White Paper
Lonza_BrandedContent_0726_FeaturedSpotlight

The Friday Brief for August 7, 2026: Mergers, Launches, and Rebrands

 
The Friday Brief for August 7, 2026: Mergers, Launches, and Rebrands

Several companies announced or completed merger deals, and there were a few new launches in the industry.
Watch Now >>

Top Headlines

Breaking News
Collaborations & Alliances

AstraZeneca, CSPC Establish New Biologics Manufacturing JV in China

The JV will initially focus on producing undisclosed biologics drug substances for global markets.

SPONSOR

[PODCAST] An Insider’s Guide to Reaching a Right-the-First-Time Tech Transfer

A closer look at the communication, scale-up, equipment, and collaboration challenges that can make or break a successful tech transfer.

Breaking News
Collaborations & Alliances

Evotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases

Odyssey will leverage Evotec’s integrated, data-driven discovery platform.

Breaking News
Collaborations & Alliances

CellFiber, Tidewave Bio to Evaluate 3D Cell Culture Platform for Scalable Manufacturing

The companies will do a joint proof-of-concept pitting the conventional 2D approach against 3D.

SPONSOR

Water for Injection: Strategic Utility and the Case for Outsourcing

Water for injection (WFI) sits at the heart of injectable drug manufacturing.

ProBio_Webinar_08-27-26_650x250

Breaking News
Collaborations & Alliances

Mediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases

These diseases are characterized by myofibroblast activation, scarring, inflammation, and tissue remodeling, and can lead to organ failure.

Featured Resources

Solution Content Center SPOTLIGHT

Solvias

Solvias is a global provider of CMC analytics to the pharmaceutical and biotech industry. Our expert teams combine 25 years of experience with regulatory understanding across small molecules, biologics, and cell and gene therapies. We offer comprehensive solutions from raw materials to drug substance & product to final release testing.

 

Solution Center SPOTLIGHT

Aphena Pharma Solutions

Aphena Pharma Solutions is service provider in the pharmaceutical, medical device and biologics industries. Through excellence and innovation, we provide clients with a full range of pharmaceutical packaging and manufacturing services to advance their products to market–complete, on time, on budget. With our continued investment in technology, advanced packaging systems and rigorous cost control, Aphena can deliver solutions that are highly cost effective as well as comprehensive. Through every step in the product launch or transfer process including laboratory support, manufacturing, packaging and distribution, we provide clients with pharmaceutical services to help ensure a successful product launch and year-over-year growth.